Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome [Phase 2]
This Phase 2 clinical trial investigates the combination of azacitidine and enasidenib for IDH2-mutant myelodysplastic syndrome and is curre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant [Phase 2]
A Phase 2 clinical trial update evaluating busulfan, fludarabine phosphate, and post-transplant cyclophosphamide in patients with hematologi…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment [NA]
A clinical trial at Ege University is evaluating whether Mandala affects anxiety and fear levels in pediatric leukemia patients before intra…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Study With Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial updating on the use of tocilizumab in combination with venetoclax and azacitidine for acute myeloid leukemia; the stu…
-
CLINICAL_TRIALS other · 2026-02-17Clinical Trial Update: Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial evaluating total marrow and lymphoid irradiation with cyclophosphamide followed by donor transplant in acute myeloid …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating memory-like natural killer cells following TCRαβ T cell-depleted haploidentical transplantation for ac…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease [Phase 1]
Phase 1 trial evaluating interferon-γ-primed mesenchymal stromal cells as prophylaxis for acute graft-versus-host disease in patients with a…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France
A completed French clinical trial reports characteristics and outcomes of acute myeloid leukemia patients treated with maintenance therapy u…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax [Phase 3]
A Phase 3 clinical trial update evaluating shortening venetoclax duration based on day 14 bone marrow blasts in elderly or frail AML patient…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia [NA]
A clinical trial is evaluating how different hemoglobin threshold-specific packed red blood cell transfusion strategies affect quality of li…
-
CLINICAL_TRIALS withdrawal · 2026-02-12Clinical Trial Update: Expanded Access to ABBV-787
Expanded access to ABBV-787 for Acute myeloid leukemia has been terminated. It is no longer available.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS [Phase 1]
Phase 1 trial SENTI-202 evaluating off-the-shelf logic-gated CAR NK cells for CD33 and/or FLT3-expressing hematologic cancers including acut…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: National Longitudinal Cohort of Hematological Diseases
Recruiting for a national longitudinal cohort study of hematological diseases sponsored by the Institute of Hematology & Blood Diseases Hosp…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Quality of Life-Guided Transfusion in Refractory MDS or AML [NA]
A clinical trial evaluating quality-of-life-guided transfusion in adults with refractory myelodysplastic syndromes or acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission [Phase 2]
Phase 2 trial evaluating oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in Japanese patients …
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia [Phase 1]
This Phase 1 clinical trial update reports dose escalation and expansion of Ziftomenib in combination with Quizartinib for Acute Myeloid Leu…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Efficacy Analysis of Comparison of CAMS（Chinese Academy of Medical Sciences）-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia
This update reports an efficacy analysis comparing the CAMS-2005 and CAMS-2009 trials in pediatric acute myeloid leukemia, with the study st…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: CLL-1/CD33 Targeted LCAR-AMDR Cells in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating CLL-1/CD33-targeted LCAR-AMDR CAR-T cells for relapsed or refractory acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: LILRB4 STAR-T Cell Therapy for Monocytic Leukemia [NA]
A clinical trial evaluating LILRB4 STAR-T Cell Therapy for monocytic leukemia has completed its study for Acute Myeloid Leukemia and Chronic…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial update reports completion of a study evaluating natural killer cell therapy in adults with acute myeloid leukemia, …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML [Phase 1, Phase 2]
This clinical trial update indicates a Phase 1/2 study evaluating venetoclax in combination with ivosidenib and azacitidine for newly diagno…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC
Clinical trial update noting completion of a study evaluating the combination of ivosidenib (TIBSOVO) with azacitidine in acute myeloid leuk…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation [NA]
The document updates a clinical trial evaluating an electronic health mindfulness-based music therapy intervention for patients undergoing a…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial [Phase 1]
Phase 1 trial DR-18 for relapsed or persistent acute myeloid leukemia or myelodysplastic syndrome after hematopoietic cell transplantation i…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists [NA]
This clinical trial updated results on UR-GOAL, a patient-centered communication tool, vs usual care for older adults with acute myeloid leu…